益气养肺祛痰化瘀解毒法治疗痰瘀互结型肺癌38例临床观察

目的:观察以肺癌合剂为代表的益气养肺祛痰化瘀解毒法治疗痰瘀互结型肺癌的临床疗效。方法:将76例痰瘀互结型非小细胞肺癌患者随机分为2组,对照组38例采用GP方案化疗,治疗4周为1周期,共治疗6周期。治疗组38例则在GP方案化疗的基础上加用益气养肺祛痰化瘀解毒之肺癌系列合剂,治疗2月为1疗程,共3疗程。观察2组患者治疗前后瘤体大小变化、主要症候改善情况、生存时间、体重、生活质量评分、毒副反应等。结果:治疗组治疗后有效率、稳定率、体重提高率、主要症候改善情况均明显优于对照组(P0.01);治疗组治疗后生存质量总积分、功能状况与对照组比较,差异有显著性意义(P0.05)。治疗组治疗后身体状况、情绪状况、症状/副作用与对照组比较,差异有非常显著性意义(P0.01)。治疗组治疗后社会/家庭状况、与医生的关系与对照组比较,差异无显著性意义(P0.05)。结论:益气养肺祛痰化瘀解毒法联合GP方案可以改善痰瘀互结型非小细胞肺癌患者的临床证候、提高临床疗效及改善生存质量。

Therapeutic Effect of Therapy of Strengthening Qi and Nourishing Lung,Resolving Phlegm and Blood-stasis,and Removing Toxins for Lung Cancer with Blending of Phlegm and Blood Stasis:An Observation of 38 Cases

Objective:To observe the therapeutic effect of Lung Cancer Mixture(LCM),which has the actions of strengthening Qi and nourishing lung,and removing phlegm,blood-stais and toxins,for the treatment of lung cancer with blending of phlegm and blood stasis.Methods:Seventy-six qualified non-small cell lung cancer patients with blending of phlegm and blood stasis were equally randomized into the control group and the treatment group.Both groups received GP regimen(gemcitabine plus carboplatin),4 weeks constituted o...